4//SEC Filing
MEDEL ROGER MD 4
Accession 0001209191-22-001141
CIK 0000893949other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:17 PM ET
Size
7.3 KB
Accession
0001209191-22-001141
Insider Transaction Report
Form 4
MEDEL ROGER MD
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-01-04$27.43/sh−87,361$2,396,312→ 852,089 total - Sale
Common Stock
2021-12-31$27.16/sh−6,564$178,278→ 939,450 total
Footnotes (3)
- [F1]Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $27.03 to $27.36 for a weighted average sales price of $27.16. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $27.19 to $27.93 for a weighted average sales price of $27.43. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeother
Related Parties
1- filerCIK 0001093125
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:17 PM ET
- Size
- 7.3 KB